These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24336007)

  • 1. Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes.
    Trojak A; Waluś-Miarka M; Woźniakiewicz E; Małecki MT; Idzior-Waluś B
    Med Sci Monit; 2013 Dec; 19():1167-72. PubMed ID: 24336007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
    Kosmalski M; Kasznicki J; Drzewoski J
    Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.
    Agarwal AK; Jain V; Singla S; Baruah BP; Arya V; Yadav R; Singh VP
    J Assoc Physicians India; 2011 Jun; 59():351-4. PubMed ID: 21751587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
    Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
    World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between nonalcoholic fatty pancreas disease and diabetes.
    Ou HY; Wang CY; Yang YC; Chen MF; Chang CJ
    PLoS One; 2013; 8(5):e62561. PubMed ID: 23671610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
    Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
    Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X
    Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional study.
    Takeuchi Y; Ito H; Komatsu Y; Oshikiri K; Antoku S; Abe M; Mifune M; Togane M
    Intern Med; 2012; 51(13):1667-75. PubMed ID: 22790124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients.
    Ma YH; Zhao L; Xian XD; Yang D; Huang W; Wang YH; Mueller O; Chang E; Konigshofer Y; Van-Cleve M; Liu G; Yang JK
    Clin Chem Lab Med; 2009; 47(9):1067-72. PubMed ID: 19728847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement.
    Zhu Z; Yang N; Fu H; Yuan G; Chen Y; Du T; Zhou X
    Front Endocrinol (Lausanne); 2022; 13():1002099. PubMed ID: 36187115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.
    Bril F; Portillo-Sanchez P; Liu IC; Kalavalapalli S; Dayton K; Cusi K
    Diabetes Care; 2018 Jan; 41(1):187-192. PubMed ID: 29133343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China.
    Kong L; Yang Y; Li H; Shan Y; Wang X; Shan X
    Front Public Health; 2023; 11():1127489. PubMed ID: 37077190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease.
    Silaghi CA; Silaghi H; Crăciun AE; Fărcaș A; Colosi HA; Cosma DT; Pais R; Hâncu N; Georgescu CE
    Med Ultrason; 2015 Sep; 17(3):300-7. PubMed ID: 26343077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women.
    Moon SS
    Ann Nutr Metab; 2013; 62(2):158-63. PubMed ID: 23406781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.